Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 1c 1125,"Rubattu S, et al., Nat Genet 1996 Aug;13(4):429-34",cerebrovascular system integrity trait,,RS:0001444,SHRSP/Bbb,both,84 days,30,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,100,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69117,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days) 1125,"Rubattu S, et al., Nat Genet 1996 Aug;13(4):429-34",cerebrovascular system integrity trait,,RS:0003421,SHR/Bbb,both,182 days,30,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,20,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 140 days) and controlled sodium content drinking water (1 %) (for 140 days) and controlled potassium content diet (6.3 mg/g) (for 140 days),69118,controlled sodium content diet (3.7 mg/g) (for 140 days),controlled sodium content drinking water (1 %) (for 140 days),controlled potassium content diet (6.3 mg/g) (for 140 days) 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0001444,SHRSP/Bbb,not specified,88 days to 70 days,31,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,100,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 70 and 88 days) and controlled sodium content drinking water (1 %) (between 70 and 88 days) and controlled potassium content diet (6.3 mg/g) (between 70 and 88 days),69119,controlled sodium content diet (3.7 mg/g) (between 70 and 88 days),controlled sodium content drinking water (1 %) (between 70 and 88 days),controlled potassium content diet (6.3 mg/g) (between 70 and 88 days) 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002192,SHRSR/Bbb,not specified,126 days,18,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,0,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69120,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days) 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,91 days to 70 days,20,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,61,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 28 and 49 days) and controlled sodium content drinking water (1 %) (between 28 and 49 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 49 days),69121,controlled sodium content diet (3.7 mg/g) (between 28 and 49 days),controlled sodium content drinking water (1 %) (between 28 and 49 days),controlled potassium content diet (6.3 mg/g) (between 28 and 49 days) 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,91 days to 70 days,34,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,63,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 28 and 49 days) and controlled sodium content drinking water (1 %) (between 28 and 49 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 49 days),69122,controlled sodium content diet (3.7 mg/g) (between 28 and 49 days),controlled sodium content drinking water (1 %) (between 28 and 49 days),controlled potassium content diet (6.3 mg/g) (between 28 and 49 days) 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,133 days to 81 days,33,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,20,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 42 and 91 days) and controlled sodium content drinking water (1 %) (between 42 and 91 days) and controlled potassium content diet (6.3 mg/g) (between 42 and 91 days),69123,controlled sodium content diet (3.7 mg/g) (between 42 and 91 days),controlled sodium content drinking water (1 %) (between 42 and 91 days),controlled potassium content diet (6.3 mg/g) (between 42 and 91 days) 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,133 days to 81 days,31,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,20,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 42 and 91 days) and controlled sodium content drinking water (1 %) (between 42 and 91 days) and controlled potassium content diet (6.3 mg/g) (between 42 and 91 days),69124,controlled sodium content diet (3.7 mg/g) (between 42 and 91 days),controlled sodium content drinking water (1 %) (between 42 and 91 days),controlled potassium content diet (6.3 mg/g) (between 42 and 91 days) 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,109 days to 70 days,33,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,100,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 28 and 67 days) and controlled sodium content drinking water (1 %) (between 28 and 67 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 67 days),84575,controlled sodium content diet (3.7 mg/g) (between 28 and 67 days),controlled sodium content drinking water (1 %) (between 28 and 67 days),controlled potassium content diet (6.3 mg/g) (between 28 and 67 days) 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,133 days to 70 days,35,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,100,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 28 and 91 days) and controlled sodium content drinking water (1 %) (between 28 and 91 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 91 days),84576,controlled sodium content diet (3.7 mg/g) (between 28 and 91 days),controlled sodium content drinking water (1 %) (between 28 and 91 days),controlled potassium content diet (6.3 mg/g) (between 28 and 91 days)